Return to homepagePandemic Pact

Development of anti-SARS-CoV-2 vaccines

Grant number: Unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    ANR

  • Principal Investigator

    Véronique GODOT

  • Research Location

    France

  • Lead Research Institution

    Institut Mondor de Recherche Biomédicale - IMRB

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The DC-CoVaC project, coordinated by Véronique Godot (UMR U955 Mondor Institute for Biomedical Research - IMRB), aims to test the immunogenicity and the preventive effect of a combination of two vaccine platforms in phase 1 to 3 of clinical development. Their approach aims to induce a polyepitopic T and B cell response. The vaccines will be tested in two preclinical models in order to study in vivo human immune responses induced by vaccines, and to demonstrate the protective effect of these vaccines.